Reduced glucose effectiveness as a feature of glucose intolerance: Evidence in elderly type-2 diabetic subjects

Aging Clinical and Experimental Research

Volumn 11, Issue 3, 1999, Pages 169-175

  Viviani, G L ^a   Pacini, G ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE

Author keywords

Beta cell secretion; Glucose tolerance; Insulin resistance; Insulin sensitivity; IVGTT; Mathematical modelling

Indexed keywords

INSULIN;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0032848252     PISSN: 03949532     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03399659     Document Type: Article

References (26)

1. Fink R.I., Kolterman O.G., Griffin J., Olefsky J.M.: Mechanisms of insulin resistance in aging. J. Clin. Invest. 71: 1523-1535, 1983.
2. Chen M., Bergman R.N., Pacini G., Porte D.Jr.: Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta cell function. J. Clin. Endocrinol. Metab. 60: 13-20, 1985.
3. Chen M., Bergman R.N., Porte D.Jr.: Insulin resistance and beta cell dysfunction in aging: the importance of dietary carbohydrate. J. Clin. Endocrinol. Metab. 67: 951-957, 1988.
4. Pacini G., Valerio A., Beccaro F., Nosadini R., Cobelli C., Crepaldi G.: Insulin sensitivity and beta cell responsivity are not decreased in elderly subjects with normal OGTT. J. Am. Geriatr. Soc. 36: 317-323, 1988.
5. Kahn S.E., Larson V.G., Beard J.C., Cain K.C., Fellingham G.W., Schwartz R.S., Veith R.C., Stratton J.R., Cerqueira M.D., Abrass I.B.: Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging. Am. J. Physiol. 258: E937-E943, 1990.
6. Harris M.I., Hadden W.C., Knowler W.C., Bennett P.M.: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 yr. Diabetes 36: 523-534, 1987.
7. Ahrén B., Pacini G.: Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man. J. Clin. Endocrinol. Metab. 83: 3350-3356, 1998.
8. Pacini G., Bergman R.N.: MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput. Methods Programs Biomed. 23: 113-122, 1986.
9. Bergman R.N.: Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 38: 1512-1527, 1989.
10. Finegood D.T.: Application of the minimal model of glucose kinetics. In: Bergman R.N., Lovejoy J.C. (Eds.), The minimal model approach and determinants of glucose tolerance. LSU Press, Baton Rouge, LA, 1997, pp. 51-122.
11. Best J.D., Kahn S.E., Ader M., Watanabe R.M., Ni T-C., Bergman R.N.: Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19: 1018-1030, 1996.
12. Basu A., Caumo A., Bettini F., Gelisio A., Alzaid A., Cobelli C., Rizza R.: Impaired basal glucose effectiveness in NIDDM. Diabetes 46: 421-432, 1997.
13. Kahn S.E., Klaff L.J., Schwartz M.W., Beard J.C., Bergman R.N., Taborsky G.J.Jr.: Treatment with a somatostatin analog decreases pancreatic beta cell and whole body sensitivity to glucose. J. Clin. Endocrinol. Metab. 71: 994-1002, 1990.
14. Meneilly G.S., Elahi D., Minaker K.L., Sclater A.L., Rowe J.W.: Impairment of noninsulin-mediated glucose disposal in the elderly. J. Clin. Endocrinol. Metab. 63: 566-571, 1989.
15. Welch S., Gebhart S.S.P., Bergman R.N., Phillips L.S.: Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J. Clin. Endocrinol. Metab. 71: 1508-1518, 1990.
16. Taniguchi A., Nakai Y., Fukushima M., Kawamura H., Imura H., Nagata I.: Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 41: 1540-1546, 1992.
17. Alzaid A.A., Dinneen S.F., Turk D.J., Caumo A., Cobelli C., Rizza R.A.: Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans. J. Clin. Invest. 94: 2341-2348, 1994.
18. Meneilly G.S., Elliott T., Tessier D., Hards L., Tildesley H.: NIDDM in the elderly. Diabetes Care 19: 1320-1325, 1996.
19. Pacini G., Tonolo G., Sambataro M., Maioli M., Ciccarese M., Brocco E., Avogaro A., Nosadini R.: Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. Am. J. Physiol. 274: E592-E599, 1998.
20. Ward W.K., Bolgiano D.C., McKnight B., Halter J.B., Porte D.Jr.: Diminished beta cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J. Clin. Invest. 74: 1318-1328, 1984.
21. Pacini G., Beccaro F., Valerio A., Nosadini R., Crepaldi G.: Reduced beta cell secretion and insulin hepatic extraction in healthy elderly subjects. J. Am. Geriatr. Soc. 38: 1283-1289, 1990.
22. Pacini G., Cobelli C.: A minimal model of C-peptide secretion and kinetics: fundamentals and clinical use. In: Cobelli C., Mariani L. (Eds.), Modelling and control in biomedical systems. Pergamon, Oxford, UK, 1989, pp. 363-369.
23. G. In: Bergman R.N., Lovejoy J.C. (Eds.), The minimal model approach and determinants of glucose tolerance. LSU Press, Baton Rouge, LA, 1997, pp. 187-201.
24. Finegood D.T., Tzur D.: Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal model method. Am. J. Physiol. 271: E485-E495, 1996.
25. Ader M., Ni T-C., Bergman R.N.: Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components. J. Clin. Invest. 99: 1187-1199, 1997.
26. Luzi L., De Fronzo R.A.: Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am. J. Physiol. 257: E241-E246, 1989.